|
Held in conjunction with  25th Annual Meeting and Expo
|
Friday, April 5, 2013. 6:00 - 8:00am
San Diego Convention Center, Room 6D
San Diego, CA
Click Here to Download Program Materials
A Comparative Effectiveness Research Roadmap for Managed Care and the Treatment of Rheumatoid Arthritis
Hot Topics Include:
- The Realistic Role of CER for to improve therapeutic decision-making
- Best practices for implementing CER in formulary and benefit designs and re-evaluations
- Characteristics of Sequenced and Targeted Therapies for RA
- Strategies to Measure and Monitor Disease Progression
Special Offering:
CME/CE-certified Comparative Effective Research/Rheumatoid Arthritis Tool Kit Available to Symposium Attendees
|
Neal Birnbaum, MD, FACP, MACR
Director, Division of Rheumatology California Pacific Medical Center Clinical Professor of Medicine Pacific Rheumatology Associates |
|
Diana Brixner, PhD, RPh
Professor and Chair, Department of Pharmacology Executive Director Outcomes Research Center, College of Pharmacy Director of Outcomes, Personalized Health Care Program University of Utah Salt Lake City, UT |
|
Jeff Dunn, PharmD, MBA
Formulary and Contract Manager SelectHealth, Inc. Salt Lake City, UT |
Who Should Attend?
This activity is designed to meet the educational needs of pharmacists, physicians and other healthcare professionals attending the AMCP 25th Annual Meeting & Expo.
Statement of Need/Program Overview
The number of new biologic and possible combinations has magnified the importance of comparative effectiveness research (CER) in rheumatoid arthritis (RA). Making coverage decisions is challenging due to the lack of data, specifically as it relates to direct cost comparisons. The use of CER will increase as more results are accessible and education on CER improves. Health plans need processes to conduct, analyze, and use CER data to understand the results in their own populations, enabling effective benefit designs and better treatment decisions. By reviewing the most current data, this symposium will guide the audience to implement evolving CER strategies for RA.
Educational Objectives
After completing this activity, the participant should be better able to:
- Explain the unique role and utility of CER to improve outcomes for the treatment of RA within a managed care setting.
- Identify currently available CER data and interpret the results for enhanced managed care decision-making for the treatment of RA.
- Apply the use of CER for the treatment of RA within a managed care setting.
- Provide accurate and appropriate counsel as part of the treatment team.
Agenda
Friday, April 5, 2013
San Diego Convention Center
Room 6D
| 6:00 am | Registration and Breakfast |
| 6:30 am |
Pre-Activity Learning Assessment
Introduction and Objectives/Opening Comments Jeff Dunn, PharmD, MBA, Moderator |
| 6:35 am |
RA Disease and Treatment Overview:
|
| 7:00 am |
CER Overview:
|
| 7:20 am |
CER for RA Implementation:
|
7:40 am | Audience Question and Answer Session | 7:55 am |
Key Takeaways and Closing Remarks
Post-Activity Assessment and Evaluation Jeff Dunn, PharmD, MBA, Moderator |
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Annenberg Center for Health Sciences at Eisenhower and Impact Education, LLC. Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Accreditation Statement
|
Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
Credit Designation
This program has been developed according to the ACPE Criteria for Quality and is assigned ACPE Universal Activity # 0797-9999-13-134-L04-P. This program is designated for up to 1.5 contact hours (0.15 CEUs) of continuing pharmacy education credit.
Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.
Type of Activity: Knowledge
Disclosure of Conflicts of Interest
The Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.
Fee Information
No additional fee is required to attend this CPE/CME activity.
Pre-registration will close at 12:00 pm on April 3. Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.
Click here to register.